Prof. Marco Coassin

Professore Ordinario di Malattie dell'Apparato Visivo, primario dell'Unità Operativa Complessa di Oftalmologia e direttore della Scuola di specializzazione in Oftalmologia. Nel 2018 è ritornato all’Università Campus Bio-Medico, dove in passato aveva conseguito la Laurea in Medicina e Chirurgia, la Specializzazione in Oftalmologia ed il Dottorato di Ricerca. Nel suo percorso professionale, si è ulteriormente specializzato negli Stati Uniti: in Patologia Oculare presso la Johns Hopkins University ed in Chirurgia Vitreo-Retinica presso la University of California a San Francisco. Ha esercitato per alcuni anni nell'Arcispedale IRCCS di Reggio Emilia. Svolge attività di ricerca in diversi campi dell'oftalmologia ed è autore di oltre 100 articoli scientifici.

2002 MD @ University Campus Bio-Medico, Rome, Italy

2004 Eye Pathology research fellowship @ Johns Hopkins University, Baltimore, USA

2006 Residency in Ophthalmology @ University Campus Bio-Medico, Rome, Italy

2007 Vitreous-Retina clinical fellowship @ University of California, San Francisco, USA

2009 Uveitis and Oncology clinical fellowship @ University of California, San Francisco, USA

2010 PhD in Ocular Immunology @ University Campus Bio-Medico, Rome, Italy

2010 – 2012 Consultant Ophthalmologist @ University Campus Bio-Medico, Rome, Italy

2012 – 2017 Consultant Ophthalmologist @ Scientific Institute for Research and Cure, Reggio Emilia, Italy

2018 – 2021 Associate Professor of Ophthalmology @ University Campus Bio-Medico, Rome, Italy

2021 → Full Professor of Ophthalmology @ University Campus Bio-Medico, Rome, Italy

2023 → Chair of Ophthalmology @ University Campus Bio-Medico, Rome, Italy

2023 → Director, Residency Program in Ophthalmology @ University Campus Bio-Medico, Rome, Italy

1. Lambiase A, Bonini S, Rasi G, Coassin M, Bruscolini A, Bonini S. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma. Arch Ophthalmol. 2003 May; 121(5):615-20.

2. Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye. 2004 Apr; 18(4):345-51.

3. Coassin M, Lambiase A, Costa N, De Gregorio A, Sgrulletta R, Sacchetti M, Aloe L, Bonini S. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. Graefes Arch Clin Exp Ophthalmol. 2005 Feb; 243(2):151-5.

4. Lambiase A, Sacchetti M, Sgrulletta R, Coassin M, Bonini S. Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer: a case report. Eur J Ophthalmol. 2005 Mar-Apr; 15(2):274-6.

5. Lenzi L, Coassin M, Lambiase A, Bonini S, Amendola T, Aloe L. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vision Res. 2005 Jun; 45(12):1491-500.

6. Coassin M, Lambiase A, Micera A, Tirassa P, Aloe L, Bonini S. Nerve growth factor modulates in vitro the expression and release of TGF-β1 by amniotic membrane. Graefes Arch Clin Exp Ophthalmol. 2006 Apr; 244(4):485-91.

7. Lambiase A, Merlo D, Mollinari C, Bonini P, Rinaldi A.M, D’Amato M, Micera A, Coassin M, Rama P, Bonini S, Garaci E. Molecular basis for keratoconus: lack of TrkA expression and its transcriptional repression by Sp3. Proc Natl Acad Sci U S A. 2005 Nov; 102(46):16795-16800.

8. Coassin M, Piovanetti O, Stark WJ, Green WR. Urate deposition in the iris and anterior chamber. Ophthalmology. 2006 Mar; 113(3):462-5.

9. Sgrulletta R, Coassin M, Bonini S. Trends in the pharmacology of inflammatory and allergic eye disorders. Anti-Inflamm. Anti-Allergy Agents Med. Chem. 2006 Nov; 5(4):357-363.

10. Lambiase A, Pagani L, Di Fausto V, Sposato V, Coassin M, Bonini S, Aloe L. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res. 2007 Jan; 1127(1):45-51.

11. Coassin M, Lambiase A, Sposato V, Micera A, Sacchetti M, Bonini S, Aloe L. NGF topical application in patients with corneal ulcer does not generate circulating NGF antibodies. Pharmacol Res. 2007 Jul; 56(1):65-9.

12. Coassin M, Piovanetti O, Stark WJ, Green WR. Urate deposits – Author reply. Ophthalmology. 2007 Oct; 114(10):1958-9.

13. Coassin M, Zhang C, Green WR, Aquavella JV, Akpek EK. Histopathological and immunological aspects of artificial corneal failure. Am J Ophthalmol. 2007 Nov; 144(5):699-704.

14. Lambiase A, Coassin M, Costa N, Lauretti P, Micera A, Ghinelli E, Aloe L, Rama P, Bonini S. Topical treatment with nerve growth factor in an animal model of herpetic keratitis. Graefes Arch Clin Exp Ophthalmol. 2008 Jan; 246(1):121-7.

15. Coassin M, Lambiase A, Sposato V, Micera A, Bonini S, Aloe L. Retinal p75 and Bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma. Graefes Arch Clin Exp Ophthalmol. 2008 Dec; 246(12):1743-9.

16. Sposato V, Bucci MG, Coassin M, Russo MA, Lambiase A, Aloe L. Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma. Neurosci Lett. 2008 Nov; 446(1):20-4.

17. Sacchetti M, Lambiase A, Coassin M, Bonini S, Bonini S. Toxic corneal ulcer: a frequent and sight-threatening disease. Eur J Ophthalmol. 2009 Nov-Dec;19(6): 916-22.

18. Lambiase A, Coassin M, Tirassa P, Mantelli F, Aloe L. Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report. Ann Ist Super Sanita. 2009;45(4):439-42.

19. Mattson MS, Huynh J, Wiseman ME, Coassin M, Kornfield JA, Schwartz D. An in vitro intact globe expansion method for evaluation of cross-linking treatments. Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3120-8.